Related Experiment Video
Updated: May 14, 2026
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Spinal cord metastasis in a patient treated with bevacizumab for glioblastoma
Anna J Lomax1, Costas K Yannakou, Mark A Rosenthal
1Department of Oncology, Royal Melbourne Hospital, Grattan Street, Parkville, Victoria, 3050, Australia. annalomax@y7mail.com
Abstract:
Spinal metastases from glioblastoma are extremely rare and may be misdiagnosed leading to a delay in investigation and treatment. Patient outcomes are poor with a high morbidity and mortality. Metastases are seen in the context of increasing survival due to improvements in glioblastoma therapies. We report a case of a patient developing a thoracic spinal cord metastasis while receiving anti-angiogenesis therapy with bevacizumab.
